Volatility Index S&P 500 Options-VIX down 0.21 to 12.72

Genentech Inc. (NYSE:DNA) option volatility at all-time lows as news flows from Analyst day. DNA is recently down $3.06 to $82.22.
DNA is providing investors today with an overview of recent developments. DNA says it "aims to bring at least 20 new molecular entities into clinical development between 2006 and 2008." Bloomberg reported DNA that said Avastin lung cancer study was stopped for safety. DNA call option volume of 12,491 contracts compares to put volume of 11,435 contracts. DNA April option implied volatility of 20 is below its 26-week of 25 according to Track Data, suggesting decreasing price risks.

Abbott Laboratories (NYSE:ABT) option implied volatility flat as ABT near 5-year high into ACC 2007. ABT is recently at $54.28.
ABT has four business segments: Diagnostic Products, Nutritional Products, Pharmaceutical Products & Vascular Products. The American College of Cardiology annual meeting takes place in New Orleans, March 24-27. ABT overall option implied volatility of 18 near its 26-week average according to Track Data, suggesting non-directional risk.

Option update - March 23, 2007 originally appeared on BloggingStocks on Fri, 23 Mar 2007 13:51:00 EST. Please see our terms for use of feeds.